Phase 1 Urothelial Carcinoma Bladder Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Urothelial Carcinoma Bladder
Aktis Oncology, Inc.150 enrolled9 locationsNCT07020117
Recruiting
Phase 1
A Study of VET3-TGI in Patients With Solid Tumors
Cervical CancerNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics60 enrolled7 locationsNCT06444815
Recruiting
Phase 1
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Gastric CancerCervical CancerCancer+7 more
Rondo Therapeutics149 enrolled2 locationsNCT07218003
Recruiting
Phase 1Phase 2
Intervention of Bladder Cancer by CAR-T
Bladder CancerUrothelial Carcinoma Bladder
Shenzhen Geno-Immune Medical Institute20 enrolled2 locationsNCT03185468
Recruiting
Phase 1
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Bladder CancerUrothelial Carcinoma Bladder
Abramson Cancer Center at Penn Medicine10 enrolled1 locationNCT06586255
Recruiting
Phase 1
Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant
Urothelial Carcinoma BladderAndrogen Receptor Positive
Brown University32 enrolled1 locationNCT05839119